DNA vaccine leads to immune responses in HPV-related head and neck cancer
(University of Pennsylvania School of Medicine) A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of Pennsylvania tested the immunotherapy approach in two groups of patients with advanced head and neck squamous cell carcinoma (HNSCCa) and found 86 percent showed elevated T cell activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 21, 2018 Category: Cancer & Oncology Source Type: news

CRISPR screen reveals new targets in more than half of all squamous cell carcinomas
(University of Colorado Anschutz Medical Campus) Team of University of Colorado Cancer Center researchers sheds light on p63 activity in squamous cell carcinoma of the lung, providing an actionable path forward to drug development against this known cause of cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news

Total of 43,371 New Cases of HPV-Associated Cancers in 2015
TUESDAY, Sept. 11, 2018 -- A total of 43,371 new cases of human papillomavirus (HPV)-associated cancers were reported in 2015, with oropharyngeal squamous cell carcinoma (SCC) being the most common HPV-associated cancer, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 11, 2018 Category: Pharmaceuticals Source Type: news

Study links widely-used drug azathioprine to skin cancers
(University of Dundee) A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development.The research, published in Nature Communications, identified a `strong case for an association' between the drug azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma (cSCC), a common form of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2018 Category: Cancer & Oncology Source Type: news

Study links widely used drug azathioprine to skin cancers
(University of Dundee) A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development.The research, published in Nature Communications, identified a 'strong case for an association' between the drug azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma (cSCC), a common form of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2018 Category: Cancer & Oncology Source Type: news

Gene Variant Linked to Risk of Oral Squamous Cell Carcinoma
A study shows significant association between MTHFR C677T polymorphisms and risk of oral squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - September 7, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Source Type: news

Voriconazole May Boost Risk of Squamous Cell Carcinoma in Transplant Patients Voriconazole May Boost Risk of Squamous Cell Carcinoma in Transplant Patients
Recipients of lung transplants (LT) or hematopoietic cell transplants (HCT) who are taking the antifungal voriconazole may be at increased risk of squamous cell carcinoma (SCC), researchers report.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 7, 2018 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news

Manual vs Automated Squamous Cell Carcinoma Antigen Assays Manual vs Automated Squamous Cell Carcinoma Antigen Assays
Does the automated Elecsys SCC assay provide comparable performance to a manual assay for determining squamous cell carcinoma antigen levels?Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 5, 2018 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Radn Tx Alone May Be Adequate for Stage I Anal Cancer in Elderly
THURSDAY, Aug. 30, 2018 -- For older patients with stage I squamous cell carcinoma of the anus, radiation alone is associated with outcomes that do not differ significantly from those of chemoradiation, according to research published in the July... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 30, 2018 Category: Pharmaceuticals Source Type: news

Alpha Tau wins approval to test cancer-targeting device in the U.S.
  Image courtesy of Alpha Tau Medical. Alpha Tau Medical can begin U.S. clinical trials of its cancer-zapping device, thanks to a new permit from the Massachusetts Radiation Control Program. The state agency granted a Sealed Source and Device (SSD) approval to the Tel Aviv company’s Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy), which enables alpha-radiation-based cancer treatment for various types of solid tumors. Alpha DaRT delivers high-precision alpha radiation that is released when radioactive substances decay inside the tumor, according to the company. The short-range alpha particles ef...
Source: Mass Device - August 21, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Gynecological Oncology Regulatory/Compliance Alpha Tau Medical Source Type: news

A review of prevalent methods for automatic skin lesion diagnosis
(Bentham Science Publishers) The three prevalent skin cancers, according to the literature are melanoma, basal cell carcinoma and squamous cell carcinoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 15, 2018 Category: International Medicine & Public Health Source Type: news

Second Primary Malignancy Risk Doubled After Head and Neck Cancer Second Primary Malignancy Risk Doubled After Head and Neck Cancer
The risk of second primary malignant neoplasm (SPMN) doubles after a first head and neck squamous cell carcinoma (HNSCC), especially when the site of the first cancer is not typically associated with malignancies due to human papillomavirus (HPV), according to a retrospective study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 27, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old
TUESDAY, July 24, 2018 -- The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a case report published online July 3... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Pazopanib/Cetuximab Combo Promising in Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma
A Washington University School of Medicine team ’s findings might inform future research into inhibitors of angiogenesis and PD-1 in head and neck cancer. (Source: CancerNetwork)
Source: CancerNetwork - July 23, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

HPV Shot Eliminates Advanced Skin Cancer in 97-Year-Old
FRIDAY, July 13, 2018 -- Two years ago, Ian McKenzie thought his mom's remaining days were dwindling. The 97-year-old woman had developed a severe case of what was thought to be an untreatable form of squamous cell carcinoma, the second leading form... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 13, 2018 Category: General Medicine Source Type: news

Living With Cancer: Understanding squamous cell carcinoma
Squamous cell carcinoma Squamous cell carcinoma is a common form of skin cancer that develops in the squamous cells that make up the middle and outer layer of your skin. Most often, the cause is prolonged exposure to ultraviolet (UV) radiation from sunlight, or from tanning beds or lamps. Avoiding UV light reduces your risk [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 6, 2018 Category: Databases & Libraries Source Type: news

Sylvester researcher uses HPV vaccine to treat patient with skin cancer
(University of Miami Miller School of Medicine) In 2017, a case report by Dr. Anna Nichols showed the HPV vaccine Gardasil reduced the number of new basal and squamous cell skin cancers in two patients. Tim Ioannides, M.D., a voluntary faculty member at UM, suggested using the vaccine as an off-label treatment by directly injecting it into the tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

New diagnosis method could help spot head and neck cancers earlier
(IOP Publishing) Oral squamous cell carcinomas (OSCCs) are the most common head and neck cancers, but are often diagnosed late.Now, researchers in Germany have developed a new cell-based test that could help provide earlier and more reliable diagnosis of OSCCs.Writing in Convergent Science Physical Oncology, the researchers explain how they tested the mechanical properties of OSCC cells, and found they were 'softer' than benign cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Flight Attendants Have Higher Rates of Many Cancers, Study Says
Flight attendants are exposed to a number of known cancer-causing risks, but few studies have rigorously quantified that risk, and researchers say they are an understudied occupational group. The Harvard Flight Attendant Health Study (FAHS), begun in 2007, addresses some of the gaps in understanding health risks among flight attendants. In the latest report, published in the journal Environmental Health, researchers found that flight attendants had higher rates of many cancers, including breast cancer and melanoma, compared to the general population. The FAHS included more than 5,300 flight attendants who were recruited th...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Peri-Implantitis and Squamous Cell Carcinoma
While Peri-implantitis has produced alot of research and is not an unusual occurrence, squamous cell carcinoma developing around dental implants is seldom described or reported.The postPeri-Implantitis and Squamous Cell Carcinoma appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - June 14, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Research and News Source Type: news

Checkpoint inhibitor shrinks advanced squamous cell skin cancer
(University of Texas M. D. Anderson Cancer Center) Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University of Texas MD Anderson Cancer Center reports in the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Merck's Keytruda extends lung cancer survival in two trials
CHICAGO (Reuters) - Merck& Co's immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous cell lung cancer, new data released on Sunday showed, further cementing the company's lead in the most lucrative oncology market. (Source: Reuters: Health)
Source: Reuters: Health - June 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Merck's Keytruda shown to extend lung cancer survival in two trials
CHICAGO (Reuters) - New trial results show that Merck& Co's Keytruda improves survival as a stand-alone treatment for newly diagnosed lung cancer and in combination with chemotherapy for hard-to-treat squamous cell lung cancer. (Source: Reuters: Health)
Source: Reuters: Health - June 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Merck's Keytruda boosts response in hard-to-treat lung cancer
(Reuters) - The combination of Merck& Co's immunotherapy Keytruda and chemotherapy boosted response rates in patients with advanced hard-to-treat squamous cell lung cancer, the company said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - May 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Spontaneous Regression of a Squamous Cell Lung Cancer Spontaneous Regression of a Squamous Cell Lung Cancer
What might be the mechanism behind the spontaneous regression of this patient's stage I squamous cell lung carcinoma?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Should You Stop Wearing Sunscreen To Get More Vitamin D? Here ’s What a Doctor Says
Last year, a study published in The Journal of the American Osteopathic Association made headlines when it asserted that sunscreen use is partially to blame for widespread vitamin D deficiency worldwide. The research raised questions, given that consistently wearing sunscreen is one of the most common pieces of advice from physicians. Should the risk of vitamin D deficiency — which can lead to brittle bones and has been associated with insulin resistance, high blood pressure and decreased immune function, among other issues — overshadow years of that advice? Not according to Dr. Victoria Werth, a professor of d...
Source: TIME: Health - May 14, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

New biomarker identified for early diagnosis of lung cancer
(Elsevier) In a novel study in The American Journal of Pathology investigators found that CKAP4 levels were significantly higher in patients with lung cancer than in healthy individuals. They further determined that CKAP4 levels are already elevated in the blood of patients with stage I disease, making it a potential noninvasive diagnostic marker that could change current practices in the diagnosis and treatment of some types of lung cancer, including non-small-cell lung cancer and squamous cell carcinoma, and improve patient outcomes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 8, 2018 Category: Biology Source Type: news

FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, April 30, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologic... Biopharmaceuticals, Oncology, FDA Regeneron Pharmaceuticals, Sanofi, cemiplimab, squamous cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2018 Category: Pharmaceuticals Source Type: news

FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
PARIS and TARRYTOWN, N.Y., April 30, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for cemiplimab for the treatment of patients with metastatic cutaneous... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 30, 2018 Category: Drugs & Pharmacology Source Type: news

Proactive Swallowing Rehab Program Helpful in Phalangeal CA
THURSDAY, April 26, 2018 -- A proactive speech and language pathology (SLP) program is beneficial for patients with head and neck squamous cell carcinoma (HNSCC), according to a study published online April 19 in JAMA Otolaryngology-Head& Neck... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2018 Category: Pharmaceuticals Source Type: news

A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment
The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A2A receptor (A2AR) and suppression of KCa3.1 channels. We conducted three-dimensional chemotaxis experiments to elucidate the effect of adenosine on the migration of peripheral blood CD8+ T cells from head and neck squamous cell carcinoma (HNSCC) patients. The chemotaxis of HNSCC CD8+ T cells was reduced in the presence of adenosine, and the effect was greater o...
Source: Signal Transduction Knowledge Environment - April 24, 2018 Category: Science Authors: Chimote, A. A., Balajthy, A., Arnold, M. J., Newton, H. S., Hajdu, P., Qualtieri, J., Wise-Draper, T., Conforti, L. Tags: STKE Research Articles Source Type: news

Most Smokers With Head and Neck Cancer Have Tried to Quit
THURSDAY, April 19, 2018 -- Most active smokers with head and neck squamous cell carcinoma (HNSCC) have made one or more quit attempts, according to a study published online April 12 in JAMA Otolaryngology-Head& Neck Surgery. Samir S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2018 Category: Pharmaceuticals Source Type: news

Sensus Healthcare inks multiple distro deals, launches global expansion project
Superficial radiation therapy device developer Sensus Healthcare (NSDQ:SRTSU) today released plans for a global expansion, including new distribution agreements in China, Germany, Mexico, Cuba and Costa Rica. Sensus makes low-energy photon X-ray systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas, and keloids. The Boca Raton, Fla.-based company refers to the technology as superficial radiation therapy, and claims that the tech has been sued to “effectively and safely treat oncological and non-oncological skin conditions.” “Following our new partnersh...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Oncology Sensus Healthcare LLC Source Type: news

Skin cancers linked with reduced risk of Alzheimer's disease
(Wiley) Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2018 Category: International Medicine & Public Health Source Type: news

Inhibiting metabolism found to be effective in treating aggressive form of lung cancer
FINDINGSResearchers from UCLA and Long Beach Memorial Medical Center have found that two targeted therapies could be more effective if used in combination to treat squamous cell carcinomas of the lung. The two drugs, MLN128 and CB-839, individually target the metabolism of key nutrients glucose and glutamine, respectively, prohibiting the cancer from switching metabolic gears between glucose (a simple sugar) and glutamine (an amino acid) to tap vital sources of energy. This switch enables the cancer cells to adapt their metabolism and evade treatments.BACKGROUNDNon-small cell lung cancer makes up about 85 percent of all lu...
Source: UCLA Newsroom: Health Sciences - April 13, 2018 Category: Universities & Medical Training Source Type: news

Inhibiting metabolism found to be effective in treating aggressive form of lung cancer
(University of California - Los Angeles Health Sciences) Researchers from UCLA and Long Beach Memorial Medical Center have found that two targeted therapies could be more effective if used in combination to treat squamous cell carcinomas of the lung (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2018 Category: Cancer & Oncology Source Type: news

NIH researchers use genomics to set squamous cell carcinomas apart from other cancers
Results could advance treatments for head and neck and other cancers. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 5, 2018 Category: American Health Source Type: news

Accurately identifying aggressive head and neck cancers
(Case Western Reserve University) Case Western Reserve University's Center for Computational Imaging and Personalized Diagnostics (CCIPD) is leading a partnership working toward the first clinical trials to determine the aggressiveness of-and appropriate treatment for-certain head and neck cancers.Head and neck cancers (squamous cell carcinomas or HNSCC) represent more than half-a-million cases and 300,000 deaths a year, making them the sixth-leading cancer worldwide, according to the World Health Organization. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 27, 2018 Category: Cancer & Oncology Source Type: news

Zimbabwe:33% of Cancers Aids Related
[263Chat] Aids related cancers namely Kaposi Sarcoma, Cervical Cancer, Non-Hodgkins Lymphoma and Squamous Cell Carcinoma of the conjunctiva continue to occupy high positions in cancer rankings, according to Zimbabwe National Cancer Registry report. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 22, 2018 Category: African Health Source Type: news

Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice
Lymph node metastases in cancer patients are associated with tumor aggressiveness, poorer prognoses, and the recommendation for systemic therapy. Whether cancer cells in lymph nodes can seed distant metastases has been a subject of considerable debate. We studied mice implanted with cancer cells (mammary carcinoma, squamous cell carcinoma, or melanoma) expressing the photoconvertible protein Dendra2. This technology allowed us to selectively photoconvert metastatic cells in the lymph node and trace their fate. We found that a fraction of these cells invaded lymph node blood vessels, entered the blood circulation, and colon...
Source: ScienceNOW - March 22, 2018 Category: Science Authors: Pereira, E. R., Kedrin, D., Seano, G., Gautier, O., Meijer, E. F. J., Jones, D., Chin, S.-M., Kitahara, S., Bouta, E. M., Chang, J., Beech, E., Jeong, H.-S., Carroll, M. C., Taghian, A. G., Padera, T. P. Tags: Medicine, Diseases reports Source Type: news

Median Household Income Predicts Survival in Anal Cancer
Lower income tied to worse overall, cancer - specific survival in squamous cell carcinoma of the anus (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 12, 2018 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Odds of Surviving Anal Cancer Colored by Income
MONDAY, March 12, 2018 -- Poorer Americans with anal cancer -- a highly treatable disease -- are more likely to die than wealthier patients, a new study finds. Researchers analyzed 2004-2013 data from 9,550 patients with squamous cell carcinoma of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 12, 2018 Category: General Medicine Source Type: news

Multimodal Imaging of Head and Neck Squamous Cell Carcinoma Multimodal Imaging of Head and Neck Squamous Cell Carcinoma
Review standard and multimodal cross-sectional imaging for evaluation and management of head and neck SCC.Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Steady Increase in Eyelid Cancer Found in England Steady Increase in Eyelid Cancer Found in England
Since 2000, the incidence of squamous cell carcinoma of the eyelid in England has increased by around 2% per year, with men affected nearly twice as often as women.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Aster, a common garden flower in America that blooms in autumn, found to be effective at preventing malignant lip and mouth cancers
(Natural News) Because of the prevalence of the many different types of cancer, it’s always a good idea to consider what kind of alternative treatments are available to you, since it is known that they can also be quite effective. This applies to oral squamous cell carcinoma (SCC), which is said to be the sixth... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2018 Category: Consumer Health News Source Type: news

Corynebacterium, Kingella Abundance Tied to HNSCC Risk
No correlation for overall microbiome composition with risk of head and neck squamous cell carcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pathology, Journal, Source Type: news

Certain factors may predict lung cancer patients' response to chemotherapy
(Wiley) In a retrospective analysis of 73 lung squamous cell carcinoma patients treated with the chemotherapy regimen of gemcitabine plus cisplatin, higher body mass index and younger age were linked with longer progression-free survival, the length of time that a patient lives with cancer but it does not get worse. Patients with better response to treatment and higher body mass index had longer overall survival in the Thoracic Cancer analysis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2018 Category: Cancer & Oncology Source Type: news

5-FU Cream Reduces Surgery in High-Risk SCC Patients 5-FU Cream Reduces Surgery in High-Risk SCC Patients
Use of a topical 5-FU cream for patients with squamous cell carcinoma (SCC) reduces the need for surgery on their face and ears, although the chemopreventive effect wanes over time.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Hydrochlorothiazide May Up Basal, Squamous Cell Cancer Risk
Increased risk for basal cell carcinoma, squamous cell carcinoma, with dose - response relationship (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 6, 2018 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Fluorouracil Tied to Reduced Surgery for Squamous Cell CA
Reduced risk of squamous cell carcinoma, but not basal cell carcinoma, for one year in at - risk veterans (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 5, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news